Relevance of Biopsy-Derived Pancreatic Organoids in the Development of Efficient Transcriptomic Signatures to Predict Adjuvant Chemosensitivity in Pancreatic Cancer
Investigators generated a prospective cohort of 27 consecutive biopsied derived pancreatic organoids and included them in the signature identification strategy.